Results 111 to 120 of about 4,992,809 (126)

<p>Tagraxofusp for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): A Brief Report on Emerging Data</p>

OncoTargets and Therapy, 2020
Loïc Ysebaert, Guillaume Béziat, Loïc Ysebaert   +2 more
exaly  

Role of tagraxofusp in treating blastic plasmacytoid dendritic cell neoplasm (BPDCN)

Expert Opinion on Biological Therapy, 2020
Mansour Alfayez, Naveen Pemmaraju
exaly  

Chronic myelomonocytic leukemia and blastic plasmacytoid dendritic cell neoplasm. A case report and systematic review

Cytometry Part B - Clinical Cytometry, 2021
José Tomás Navarro Ferrando, Blanca Xicoy, Marc Sorigué   +2 more
exaly  

Blastic Plasmacytoid Dendritic Cell Neoplasm: From Origin of the Cell to Targeted Therapies

Biology of Blood and Marrow Transplantation, 2016
Jonathan Farhi, Kamel Laribi, Pierre Lemaire   +2 more
exaly  

Molecular Features of Blastic Plasmacytoid Dendritic Cell Neoplasm

Hematology/Oncology Clinics of North America, 2020
Stefano Pileri, Maria Rosaria Sapienza
exaly  

Blastic Plasmacytoid Dendritic Cell Neoplasm: State of the Art and Prospects

Cancers, 2019
Giovanna Motta, Stefano Pileri, Alessandro Pileri   +2 more
exaly  

The lenalidomide/bortezomib/dexamethasone regimen for the treatment of blastic plasmacytoid dendritic cell neoplasm

Hematological Oncology, 2019
Vincent Marmouset
exaly  

Blastic plasmacytoid dendritic cell neoplasm: a single-center experience

Annals of Hematology, 2012
Su-Jin Shin, Jooryung Huh, Kyoo-Hyung Lee   +2 more
exaly  

Morphologic Characteristics of Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report

Ultrastructural Pathology, 2014
Yingchang Mi, Shuxu Dong
exaly  

A rare case of blastic plasmacytoid dendritic cell neoplasm with deletion 7q.31, in the setting of heavy pre-treatment with alkylating chemotherapy

Journal of Oncology Pharmacy Practice, 2017
Sara Shalin, Varinder Kaur, Yogesh Jethava   +2 more
exaly